Tekmira Raises Money
Long Ideas - Editor’s Note: A version of this commentary was sent to PropThink Premium subscribers on the morning of Thursday, October 17. On Friday the 18th, TKMR … Continue Reading
Read nowMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Galectin and Ziopharm: Quality Progress or Creative Tail-Wagging?
Insights - A tweet from Adam Feuerstein, senior biotech correspondent for TheStreet.com, piqued our interest last week. The comment caught our eye because of the likelihood that … Continue Reading
Read nowWhy Zerenex Could Be More than Just a Dialysis Product
Long Ideas - Early this year, Keryx Biopharmaceuticals (KERX) reported strong Phase III results for its phosphate binder Zerenex (ferric citrate) in dialysis patients, sending the stock from … Continue Reading
Read nowInvestors Overdid the Endocyte Sell-Off
Long Ideas - With the stock down 20% in early morning trading on Friday, October 11, PropThink wrote to PropThink Premium subscribers that Endocyte’s (ECYT) weakness offered another buying opportunity … Continue Reading
Read nowPropThink’s Recap from a Troubled Market Week
Most Popular - At PropThink, the story of the day on Friday was the sell-off in Endocyte, Inc (ECYT). Endocyte‘s lead asset is vintafolide, a folate receptor-targeting small … Continue Reading
Read nowBIND Therapeutics Had a Muted IPO but the Thesis Intrigues
Long Ideas - 2013 has been a banner year for biotech IPO’s, with a number of companies making their public debuts to strong reception by the market. BIND … Continue Reading
Read nowA Recap of PropThink’s Top Trades this Week
Most Popular - Our open conference call with Tekmira Pharmaceuticals’ (TKMR) CEO Dr. Mark Murray on Thursday afternoon was a success on a number of fronts – participation, … Continue Reading
Read now